PORTLAND, Ore. – By the time her mother received the e-mail, Yuna Lee was 2 years old, a child with a frightening medical mystery. Plagued with body-rattling seizures, she could not speak, walk or stand.
"Why is she suffering so much?" her mother, Soo-Kyung Lee, anguished. Brain scans, genetic tests and neurological exams yielded no answers. But when an e-mail popped up suggesting that Yuna might have a mutation on a gene called FOXG1, Lee froze. "I knew," she said, "what that gene was."
Almost no one else in the world would have had any idea. But Lee is a specialist in the genetics of the brain — "a star," said Robert Riddle, a program director in neurogenetics at the National Institute of Neurological Disorders and Stroke.
For years, Lee, a developmental biologist at Oregon Health and Science University, had worked with the FOX family of genes. She also knew harmful FOXG1 mutations are exceedingly rare. Only about 300 people worldwide are known to have the condition.
"It is an astounding story," Riddle said. "A basic researcher working on something that might help humanity, and it turns out it directly affects her child."
Suddenly, Lee, 42, and her husband, Jae Lee, 57, another genetics specialist at OHSU, had to transform from dispassionate scientists into parents of a patient, plunged into a fast-moving ocean of newly identified gene mutations, newly named diagnoses and answers that raise new questions. The newfound capacity to sequence genomes is spurring a genetic gold rush, linking mystifying diseases to specific mutations — often random mutations not passed down from parents.
Yuna is now a sweet-natured 8-year-old still wearing a toddler's onesie over a diaper. "Cognitively she's about 18 months," said Jae Lee.
Shortly after Yuna's second birthday, Soo-Kyung Lee traveled to Washington, D.C., to serve on a National Institutes of Health panel. At dinner, she found herself next to Dr. David Rowitch, a neonatologist and neuroscientist she knew only by reputation.